Endocarditis due to group D streptococci. Comparison of disease caused by streptococcus bovis with that produced by the enterococci.
D000667:Ampicillin / Q000627:therapeutic use; D001900:Boston; D002509:Cephaloridine / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D004697:Endocarditis, Bacterial / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D004917:Erythromycin / Q000627:therapeutic use; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D008712:Methicillin / Q000627:therapeutic use; D008826:Microbial Sensitivity Tests; D010068:Oxacillin / Q000627:therapeutic use; D010406:Penicillins / Q000494:pharmacology / Q000627:therapeutic use; D012189:Retrospective Studies; D013045:Species Specificity; D013290:Streptococcal Infections / Q000188:drug therapy; D013291:Streptococcus / Q000187:drug effects / Q000302:isolation & purification*; D014640:Vancomycin / Q000627:therapeutic use
D005839:Gentamicins; D010406:Penicillins; D007612:Kanamycin; D004917:Erythromycin; D002701:Chloramphenicol; D014640:Vancomycin; D000667:Ampicillin; D002509:Cephaloridine; D008712:Methicillin; D002512:Cephalothin; D010068:Oxacillin